Panax notoginseng extract doubles the hemolysis function

Cardiovascular disease is still on the rise in China The treatment of coronary heart disease in young people is not optimistic, and premature death is serious On May 10, China cardiovascular disease report 2015 (hereinafter referred to as the report) compiled by the National Cardiovascular Center was officially published The report shows that the risk factors of cardiovascular disease are generally exposed in China, and the prevalence of hypertension, dyslipidemia, diabetes and obesity continues to increase Gao runlin, academician of the National Center for cardiovascular diseases, said that in the face of the extremely severe situation of cardiovascular disease, strengthening public health education and community population prevention and control are the key Professor Li Lianda, academician of the Chinese Academy of engineering and expert of Chinese medicine pharmacology, said that modern medical research shows that notoginseng contains saponins, notoginseng element, notoginseng polysaccharide, amino acids and other effective ingredients, which has a unique therapeutic and health care effect on blood system, cardiovascular and cerebrovascular system, central nervous system and other diseases, and is a rare and precious medicinal material to maintain human health The hemolysis experiment of Panax notoginseng shocked people's report that the mortality of cardiovascular disease in China is higher than that of tumor and other diseases Two out of every five deaths in the country are from cardiovascular and cerebrovascular diseases It is understood that cardiovascular and cerebrovascular diseases are not only killers of human health, but also have a trend of youth, becoming the main cause of "overwork death" of young people However, cardiovascular and cerebrovascular diseases are caused by "junk blood" characterized by hyperlipidemia, which leads to "Scaling" and "blockage" of blood vessels It can be said that it is the necessary way to prevent and treat cardiovascular and cerebrovascular diseases by dissolving thrombus in blood vessels, removing rubbish in blood and unblocking blood circulation Panax notoginseng has been widely recognized as a good medicine for the prevention and treatment of cardiovascular and cerebrovascular diseases, which is strongly confirmed by Cui's hemolysis experiment—— The chicken blood diluted with water will coagulate naturally soon, just like tofu; the chicken blood with Sanqi powder is still liquid and will not coagulate for a long time; the chicken blood with a small amount of Sanqi extract will keep liquid for a longer time, with higher purity and brighter color This experiment makes ordinary people know that Sanqi powder has hemolytic function, and the hemolytic ability of Sanqi extract is greater than that of Sanqi powder Why is the hemolysis function of notoginseng extract better? "At present, a large number of notoginseng applications are limited to such rough processing as slicing and powdering Not only a lot of precious 37 resources are wasted, but also the effect is low Compared with the rough processing of Sanqi powder, Sanqi extract no longer has the interference of hemostatic substances " Cui said He further explained that Panax notoginseng itself has two completely opposite two-way regulatory functions of hemostasis and hemolysis Compared with the simple rough processing of Panax Notoginseng Powder, Panax notoginseng extract has separated Panax notoginseng with hemostatic effect, and only retained the single substance of Panax notoginseng total saponin with hemolytic function, that is, there is no interference of hemostatic function substance, so the hemolytic effect is greatly improved It is understood that with the progress of modern medical technology, through the extraction and secondary refining process, Panax notoginseng extract has been processed into Panax notoginseng series of drugs and health food, such as high active injection, high-purity oral agent and high safety soft capsule, and widely used in the prevention and health care of cardiovascular and cerebrovascular diseases and related diseases, such as arteriosclerosis, high blood viscosity, cerebral thrombosis , coronary heart disease and angina pectoris, and the pace of entering the international pharmaceutical market is speeding up It has successively entered the international markets such as Japan and the United States, and has been included in the French Pharmacopoeia, bringing health benefits to more people with cardiovascular and cerebrovascular problems.